PUBLICATION

Melanoma Regression and Recurrence in Zebrafish

Authors
Wojciechowska, S., Zeng, Z., Lister, J.A., Ceol, C.J., Patton, E.E.
ID
ZDB-PUB-160729-20
Date
2016
Source
Methods in molecular biology (Clifton, N.J.)   1451: 143-53 (Chapter)
Registered Authors
Ceol, Craig, Lister, James A., Patton, E. Elizabeth, Zeng, Zhiqiang
Keywords
Melanoma, Mitf, Recurrence, Regression, Zebrafish cancer models
MeSH Terms
  • Animals
  • Humans
  • Immunohistochemistry
  • Melanoma/genetics
  • Melanoma/metabolism
  • Melanoma/pathology*
  • Microphthalmia-Associated Transcription Factor/genetics
  • Microphthalmia-Associated Transcription Factor/metabolism
  • Neoplasms/genetics
  • Neoplasms/pathology*
  • Proto-Oncogene Proteins B-raf/genetics
  • Zebrafish/genetics
  • Zebrafish/metabolism*
PubMed
27464806 Full text @ Meth. Mol. Biol.
Abstract
Melanoma is the most lethal form of skin cancer with high mortality rates. Most melanoma cases have activating mutations in BRAF (V600E) and the selective inhibitors of BRAF(V600E) have been successfully used in patients. However, after initial tumor regression, the majority of patients develop drug resistance resulting in tumor regrowth. It is therefore important to understand the mechanisms underlying these processes. We have recently described the role of the master melanocyte transcription factor MITF in tumor growth, regression, and recurrence. Here, we describe protocols to study regression and recurrence in vivo, as well as for histology and immunohistochemistry, using a temperature-sensitive zebrafish model of human melanoma.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping